Implications of controlling for comorbid conditions in cost-of-illness estimates: A case study of osteoarthritis from a managed care system perspective

Value in Health

Volumn 4, Issue 4, 2001, Pages 329-334

  Lee, David W ^a   Meyer, Jay W ^b   Clouse, Jon ^b  

^a PFIZER INC   (United States)

^b Ingenix Inc   (United States)

Author keywords

Cost; Cost of illness; Methodology; Osteoarthritis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; OSTEOARTHRITIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL MODEL;

EID: 0034873268     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2001.44012.x     Document Type: Article

References (14)

1. Direct medical costs unique to people with arthritis
2. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
3. Health care utilization and costs among patients treated for bipolar disorder in an insured population
4. Patterns of health care costs associated with depression and substance abuse in a national sample
5. Type 2 diabetes: Incremental medical care costs during the first 8 years after diagnosis
6. Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO
7. Excess costs of medical care for patients with diabetes in a managed care population
8. The economic burden of asthma in US children: Estimates from the national medical expenditure survey
9. Health care costs of primary care patients with recognized depression
10. Costs attributable to osteoarthritis
11. Chronic care costs in managed care
12. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs